The expression and localisation of mRNAs for 5 alpha reductase Type I (5 alpha R-I) and Type II (5 alpha R-II) isoenzymes in human benign prostatic hyperplasia (BPH) were investigated by RT-PCR and by in mini hybridisation (ISH) using digoxigenin labelled riboprobes. In addition, we also examined the isoenzymes mRNA expression in primary BPH cultures of separated stroma/fibroblast and epithelial cells to determine whether primary cultures are appropriate models in which to investigate 5 alpha R activity and regulation. The results demonstrated conclusively the presence of mRNA encoding both isoenzymes in all specimens so far examined. Additionally, the presence of a functional 5 alpha R-I and -II activity in BPH was confirmed by enzyme assays. ISH studies localised the mRNA expression to both the fibroblast/stromal component as well as the epithelial cells of the hyperplastic tissue. In the glandular regions the expression for both isoenzymes was particularly strong in the basal layers of the epithelium whereas mRNA expression in the secretory cells was less pronounced. Expression of 5 alpha R-I and -II mRNAs in fibroblast was on the other hand variable with high expression in some areas and little in others. These findings were supported by our primary culture experiments which demonstrated that both the fibroblast and epithelial cells maintain a capacity to express both isoenzymes in vitro. In the case of the fibroblast, the capacity to express the isoenzymes was maintained following the sequential passaging of the cells up to passage 6, after which the cells no longer expressed either isoenzyme.

This article has been cited by other articles:

				D. R. Bauman, S. Steckelbroeck, D. M. Peehl, and T. M. Penning Transcript Profiling of the Androgen Signal in Normal Prostate, Benign Prostatic Hyperplasia, and Prostate Cancer Endocrinology, December 1, 2006; 147(12): 5806 - 5816. [Abstract] [Full Text] [PDF]

				S. Thiele, U. Hoppe, P.-M. Holterhus, and O. Hiort Isoenzyme type 1 of 5alpha-reductase is abundantly transcribed in normal human genital skin fibroblasts and may play an important role in masculinization of 5alpha-reductase type 2 deficient males Eur. J. Endocrinol., June 1, 2005; 152(6): 875 - 880. [Abstract] [Full Text] [PDF]

				S. J. Assinder, C. Johnson, K. King, and H. D. Nicholson Regulation of 5{alpha}-Reductase Isoforms by Oxytocin in the Rat Ventral Prostate Endocrinology, December 1, 2004; 145(12): 5767 - 5773. [Abstract] [Full Text] [PDF]

				L. J. Schmidt, H. Murillo, and D. J. Tindall Gene Expression in Prostate Cancer Cells Treated With the Dual 5 Alpha-Reductase Inhibitor Dutasteride J Androl, November 1, 2004; 25(6): 944 - 953. [Abstract] [Full Text] [PDF]

				C. Martin, M. Ross, K. E. Chapman, R. Andrew, P. Bollina, J. R. Seckl, and F. K. Habib CYP7B Generates a Selective Estrogen Receptor {beta} Agonist in Human Prostate J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2928 - 2935. [Abstract] [Full Text] [PDF]

				R. V. Clark, D. J. Hermann, G. R. Cunningham, T. H. Wilson, B. B. Morrill, and S. Hobbs Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5{alpha}-Reductase Inhibitor J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2179 - 2184. [Abstract] [Full Text] [PDF]

				F. K. Habib, M. Ross, C. W. Bayne, P. Bollina, K. Grigor, and K. Chapman The Loss of 5{alpha}-Reductase Type I and Type II mRNA Expression in Metastatic Prostate Cancer to Bone and Lymph Node Metastasis Clin. Cancer Res., May 1, 2003; 9(5): 1815 - 1819. [Abstract] [Full Text] [PDF]

				Y. Asada, T. Sonoda, M. Ojiro, S. Kurata, T. Sato, T. Ezaki, and S. Takayasu 5{{alpha}}-Reductase Type 2 Is Constitutively Expressed in the Dermal Papilla and Connective Tissue Sheath of the Hair Follicle in Vivo But Not during Culture in Vitro J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2875 - 2880. [Abstract] [Full Text] [PDF]

				M. El-Alfy, V. Luu-The, X.-F. Huang, L. Berger, F. Labrie, and G. Pelletier Localization of Type 5 17{beta}-Hydroxysteroid Dehydrogenase, 3{beta}-Hydroxysteroid Dehydrogenase, and Androgen Receptor in the Human Prostate by in Situ Hybridization and Immunocytochemistry Endocrinology, March 1, 1999; 140(3): 1481 - 1491. [Abstract] [Full Text]